▶ 調査レポート

関節リウマチ用薬の世界市場:インサイト・予測

• 英文タイトル:Global Drugs for Rheumatoid Arthritis Market Insights, Forecast to 2025

QYResearchが調査・発行した産業分析レポートです。関節リウマチ用薬の世界市場:インサイト・予測 / Global Drugs for Rheumatoid Arthritis Market Insights, Forecast to 2025 / QYR9ST00130資料のイメージです。• レポートコード:QYR9ST00130
• 出版社/出版日:QYResearch / 2019年9月2日
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥429,000 (USD3,900)▷ お問い合わせ
  Enterprise License¥858,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートでは、世界の関節リウマチ用薬市場について調査・分析し、以下の構成でお届け致します。関節リウマチ用薬の種類別には、処方箋、OTCに、用途別には、病院、診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別関節リウマチ用薬売上データ
・地域別関節リウマチ用薬市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別関節リウマチ用薬市場規模:処方箋、OTC
・用途別関節リウマチ用薬市場規模:病院、診療所、その他
・主要メーカーの企業情報:AbbVie Inc、Hoffman-La Roche AG、Amgen Inc、Pfizer Inc、Bristol-Myers Squibb Co、Johnson & Johnson、UCB Biosciences Inc、Mitsubishi Tanabe Pharma Corp、Biogen Inc、Merck & Co、Market Segment by Product Type、Pharmaceuticals、Biopharmaceuticals
・関節リウマチ用薬の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

Rheumatoid arthritis can be difficult to diagnose in its early stages because the early signs and symptoms mimic those of many other diseases. There is no one blood test or physical finding to confirm the diagnosis.The global Drugs for Rheumatoid Arthritis market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drugs for Rheumatoid Arthritis market based on company, product type, end user and key regions.

This report studies the global market size of Drugs for Rheumatoid Arthritis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Rheumatoid Arthritis in these regions.
This research report categorizes the global Drugs for Rheumatoid Arthritis market by top players/brands, region, type and end user. This report also studies the global Drugs for Rheumatoid Arthritis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie Inc
Hoffman-La Roche AG
Amgen Inc
Pfizer Inc
Bristol-Myers Squibb Co
Johnson & Johnson
UCB Biosciences Inc
Mitsubishi Tanabe Pharma Corp
Biogen Inc
Merck & Co
Market Segment by Product Type
Pharmaceuticals
Biopharmaceuticals

Market size by Product
Prescription
OTC
Market size by End User
Hospital
Clinics
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Drugs for Rheumatoid Arthritis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Drugs for Rheumatoid Arthritis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drugs for Rheumatoid Arthritis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drugs for Rheumatoid Arthritis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Drugs for Rheumatoid Arthritis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drugs for Rheumatoid Arthritis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Study Coverage
1.1 Drugs for Rheumatoid Arthritis Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Drugs for Rheumatoid Arthritis Market Size Growth Rate by Product
1.4.2 Prescription
1.4.3 OTC
1.5 Market by End User
1.5.1 Global Drugs for Rheumatoid Arthritis Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Drugs for Rheumatoid Arthritis Market Size
2.1.1 Global Drugs for Rheumatoid Arthritis Revenue 2014-2025
2.1.2 Global Drugs for Rheumatoid Arthritis Sales 2014-2025
2.2 Drugs for Rheumatoid Arthritis Growth Rate by Regions
2.2.1 Global Drugs for Rheumatoid Arthritis Sales by Regions
2.2.2 Global Drugs for Rheumatoid Arthritis Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Drugs for Rheumatoid Arthritis Sales by Manufacturers
3.1.1 Drugs for Rheumatoid Arthritis Sales by Manufacturers
3.1.2 Drugs for Rheumatoid Arthritis Sales Market Share by Manufacturers
3.1.3 Global Drugs for Rheumatoid Arthritis Market Concentration Ratio (CR5 and HHI)
3.2 Drugs for Rheumatoid Arthritis Revenue by Manufacturers
3.2.1 Drugs for Rheumatoid Arthritis Revenue by Manufacturers (2014-2019)
3.2.2 Drugs for Rheumatoid Arthritis Revenue Share by Manufacturers (2014-2019)
3.3 Drugs for Rheumatoid Arthritis Price by Manufacturers
3.4 Drugs for Rheumatoid Arthritis Manufacturing Base Distribution, Product Types
3.4.1 Drugs for Rheumatoid Arthritis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drugs for Rheumatoid Arthritis Product Type
3.4.3 Date of International Manufacturers Enter into Drugs for Rheumatoid Arthritis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Drugs for Rheumatoid Arthritis Sales by Product
4.2 Global Drugs for Rheumatoid Arthritis Revenue by Product
4.3 Drugs for Rheumatoid Arthritis Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Drugs for Rheumatoid Arthritis Breakdown Data by End User

6 North America
6.1 North America Drugs for Rheumatoid Arthritis by Countries
6.1.1 North America Drugs for Rheumatoid Arthritis Sales by Countries
6.1.2 North America Drugs for Rheumatoid Arthritis Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Drugs for Rheumatoid Arthritis by Product
6.3 North America Drugs for Rheumatoid Arthritis by End User

7 Europe
7.1 Europe Drugs for Rheumatoid Arthritis by Countries
7.1.1 Europe Drugs for Rheumatoid Arthritis Sales by Countries
7.1.2 Europe Drugs for Rheumatoid Arthritis Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drugs for Rheumatoid Arthritis by Product
7.3 Europe Drugs for Rheumatoid Arthritis by End User

8 Asia Pacific
8.1 Asia Pacific Drugs for Rheumatoid Arthritis by Countries
8.1.1 Asia Pacific Drugs for Rheumatoid Arthritis Sales by Countries
8.1.2 Asia Pacific Drugs for Rheumatoid Arthritis Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Drugs for Rheumatoid Arthritis by Product
8.3 Asia Pacific Drugs for Rheumatoid Arthritis by End User

9 Central & South America
9.1 Central & South America Drugs for Rheumatoid Arthritis by Countries
9.1.1 Central & South America Drugs for Rheumatoid Arthritis Sales by Countries
9.1.2 Central & South America Drugs for Rheumatoid Arthritis Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Drugs for Rheumatoid Arthritis by Product
9.3 Central & South America Drugs for Rheumatoid Arthritis by End User

10 Middle East and Africa
10.1 Middle East and Africa Drugs for Rheumatoid Arthritis by Countries
10.1.1 Middle East and Africa Drugs for Rheumatoid Arthritis Sales by Countries
10.1.2 Middle East and Africa Drugs for Rheumatoid Arthritis Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Drugs for Rheumatoid Arthritis by Product
10.3 Middle East and Africa Drugs for Rheumatoid Arthritis by End User

11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Details
11.1.2 Company Business Overview
11.1.3 AbbVie Inc Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AbbVie Inc Drugs for Rheumatoid Arthritis Products Offered
11.1.5 AbbVie Inc Recent Development
11.2 Hoffman-La Roche AG
11.2.1 Hoffman-La Roche AG Company Details
11.2.2 Company Business Overview
11.2.3 Hoffman-La Roche AG Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Hoffman-La Roche AG Drugs for Rheumatoid Arthritis Products Offered
11.2.5 Hoffman-La Roche AG Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Company Business Overview
11.3.3 Amgen Inc Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Amgen Inc Drugs for Rheumatoid Arthritis Products Offered
11.3.5 Amgen Inc Recent Development
11.4 Pfizer Inc
11.4.1 Pfizer Inc Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Inc Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Inc Drugs for Rheumatoid Arthritis Products Offered
11.4.5 Pfizer Inc Recent Development
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Details
11.5.2 Company Business Overview
11.5.3 Bristol-Myers Squibb Co Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bristol-Myers Squibb Co Drugs for Rheumatoid Arthritis Products Offered
11.5.5 Bristol-Myers Squibb Co Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Company Business Overview
11.6.3 Johnson & Johnson Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Johnson & Johnson Drugs for Rheumatoid Arthritis Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 UCB Biosciences Inc
11.7.1 UCB Biosciences Inc Company Details
11.7.2 Company Business Overview
11.7.3 UCB Biosciences Inc Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.7.4 UCB Biosciences Inc Drugs for Rheumatoid Arthritis Products Offered
11.7.5 UCB Biosciences Inc Recent Development
11.8 Mitsubishi Tanabe Pharma Corp
11.8.1 Mitsubishi Tanabe Pharma Corp Company Details
11.8.2 Company Business Overview
11.8.3 Mitsubishi Tanabe Pharma Corp Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Mitsubishi Tanabe Pharma Corp Drugs for Rheumatoid Arthritis Products Offered
11.8.5 Mitsubishi Tanabe Pharma Corp Recent Development
11.9 Biogen Inc
11.9.1 Biogen Inc Company Details
11.9.2 Company Business Overview
11.9.3 Biogen Inc Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Biogen Inc Drugs for Rheumatoid Arthritis Products Offered
11.9.5 Biogen Inc Recent Development
11.10 Merck & Co
11.10.1 Merck & Co Company Details
11.10.2 Company Business Overview
11.10.3 Merck & Co Drugs for Rheumatoid Arthritis Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Merck & Co Drugs for Rheumatoid Arthritis Products Offered
11.10.5 Merck & Co Recent Development
11.11 Market Segment by Product Type
11.12 Pharmaceuticals
11.13 Biopharmaceuticals

12 Future Forecast
12.1 Drugs for Rheumatoid Arthritis Market Forecast by Regions
12.1.1 Global Drugs for Rheumatoid Arthritis Sales Forecast by Regions 2019-2025
12.1.2 Global Drugs for Rheumatoid Arthritis Revenue Forecast by Regions 2019-2025
12.2 Drugs for Rheumatoid Arthritis Market Forecast by Product
12.2.1 Global Drugs for Rheumatoid Arthritis Sales Forecast by Product 2019-2025
12.2.2 Global Drugs for Rheumatoid Arthritis Revenue Forecast by Product 2019-2025
12.3 Drugs for Rheumatoid Arthritis Market Forecast by End User
12.4 North America Drugs for Rheumatoid Arthritis Forecast
12.5 Europe Drugs for Rheumatoid Arthritis Forecast
12.6 Asia Pacific Drugs for Rheumatoid Arthritis Forecast
12.7 Central & South America Drugs for Rheumatoid Arthritis Forecast
12.8 Middle East and Africa Drugs for Rheumatoid Arthritis Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drugs for Rheumatoid Arthritis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Drugs for Rheumatoid Arthritis Product Picture
Table Drugs for Rheumatoid Arthritis Market Segments
Table Key Manufacturers Drugs for Rheumatoid Arthritis Covered
Table Global Drugs for Rheumatoid Arthritis Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Drugs for Rheumatoid Arthritis Sales Market Share by Product 2014-2025
Figure Prescription Product Picture
Table Major Manufacturers of Prescription
Figure OTC Product Picture
Table Major Manufacturers of OTC
Table Global Drugs for Rheumatoid Arthritis Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Clinics
Figure Other
Figure Drugs for Rheumatoid Arthritis Report Years Considered
Figure Global Drugs for Rheumatoid Arthritis Market Size 2014-2025 (Million US$)
Figure Global Drugs for Rheumatoid Arthritis Sales 2014-2025 (K Units)
Table Global Drugs for Rheumatoid Arthritis Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Drugs for Rheumatoid Arthritis Sales by Regions 2014-2019 (K Units)
Table Global Drugs for Rheumatoid Arthritis Sales Market Share by Regions 2014-2019
Figure Global Drugs for Rheumatoid Arthritis Sales Market Share by Regions 2014-2019
Figure 2018 Global Drugs for Rheumatoid Arthritis Sales Market Share by Regions
Table Global Drugs for Rheumatoid Arthritis Revenue by Regions 2014-2019 (Million US$)
Table Global Drugs for Rheumatoid Arthritis Revenue Market Share by Regions 2014-2019
Figure Global Drugs for Rheumatoid Arthritis Revenue Market Share by Regions 2014-2019
Figure 2018 Global Drugs for Rheumatoid Arthritis Revenue Market Share by Regions
Table Global Drugs for Rheumatoid Arthritis Sales by Manufacturers (2014-2019) (K Units)
Table Global Drugs for Rheumatoid Arthritis Sales Share by Manufacturers (2014-2019)
Figure Global Drugs for Rheumatoid Arthritis Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Drugs for Rheumatoid Arthritis Revenue by Manufacturers (2014-2019) (Million USD)
Table Drugs for Rheumatoid Arthritis Revenue Share by Manufacturers (2014-2019)
Figure Drugs for Rheumatoid Arthritis Value Share by Manufacturers in 2018
Table Key Manufacturers Drugs for Rheumatoid Arthritis Price (2014-2019) (USD/Unit)
Table Drugs for Rheumatoid Arthritis Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Drugs for Rheumatoid Arthritis Product Type
Table Date of International Manufacturers Enter into Drugs for Rheumatoid Arthritis Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Drugs for Rheumatoid Arthritis Sales by Product (2014-2019) (K Units)
Table Global Drugs for Rheumatoid Arthritis Sales Share by Product (2014-2019)
Figure Global Drugs for Rheumatoid Arthritis Sales Market Share by Product (2014-2019)
Figure Global Drugs for Rheumatoid Arthritis Sales Market Share by Product in 2018
Table Global Drugs for Rheumatoid Arthritis Revenue by Product (2014-2019) (Million US$)
Table Global Drugs for Rheumatoid Arthritis Revenue Share by Product (2014-2019)
Figure Global Drugs for Rheumatoid Arthritis Revenue Market Share by Product (2014-2019)
Figure Global Drugs for Rheumatoid Arthritis Revenue Market Share by Product in 2018
Table Drugs for Rheumatoid Arthritis Price by Product 2014-2019 (USD/Unit)
Table Global Drugs for Rheumatoid Arthritis Sales by End User (2014-2019) (K Units)
Table Global Drugs for Rheumatoid Arthritis Sales Share by End User (2014-2019)
Figure Global Sales Drugs for Rheumatoid Arthritis Market Share by End User (2014-2019)
Figure Global Sales Drugs for Rheumatoid Arthritis Market Share by End User in 2018
Figure North America Drugs for Rheumatoid Arthritis Sales Growth Rate 2014-2019 (K Units)
Figure North America Drugs for Rheumatoid Arthritis Revenue Growth Rate 2014-2019 (Million US$)
Table North America Drugs for Rheumatoid Arthritis Sales by Countries (2014-2019) (K Units)
Table North America Drugs for Rheumatoid Arthritis Sales Market Share by Countries (2014-2019)
Figure 2018 North America Drugs for Rheumatoid Arthritis Sales Market Share by Countries
Table North America Drugs for Rheumatoid Arthritis Revenue by Countries (2014-2019) (Million US$)
Table North America Drugs for Rheumatoid Arthritis Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Drugs for Rheumatoid Arthritis Revenue Market Share by Countries
Figure United States Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure United States Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Canada Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Table North America Drugs for Rheumatoid Arthritis Sales by Product (2014-2019) (K Units)
Table North America Drugs for Rheumatoid Arthritis Sales Market Share by Product (2014-2019)
Figure 2018 North America Drugs for Rheumatoid Arthritis Market Share by Product
Table North America Drugs for Rheumatoid Arthritis Sales by End User (2014-2019) (K Units)
Table North America Drugs for Rheumatoid Arthritis Sales Market Share by End User (2014-2019)
Figure 2018 North America Drugs for Rheumatoid Arthritis Market Share by End User
Figure Europe Drugs for Rheumatoid Arthritis Sales Growth Rate 2014-2019 (K Units)
Figure Europe Drugs for Rheumatoid Arthritis Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Drugs for Rheumatoid Arthritis Sales by Countries (2014-2019) (K Units)
Table Europe Drugs for Rheumatoid Arthritis Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Drugs for Rheumatoid Arthritis Sales Market Share by Countries
Table Europe Drugs for Rheumatoid Arthritis Revenue by Countries (2014-2019) (Million US$)
Table Europe Drugs for Rheumatoid Arthritis Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Drugs for Rheumatoid Arthritis Revenue Market Share by Countries
Figure Germany Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Germany Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure France Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure France Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure UK Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Italy Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Russia Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Drugs for Rheumatoid Arthritis Sales by Product (2014-2019) (K Units)
Table Europe Drugs for Rheumatoid Arthritis Sales Market Share by Product (2014-2019)
Figure 2018 Europe Drugs for Rheumatoid Arthritis Market Share by Product
Table Europe Drugs for Rheumatoid Arthritis Sales by End User (2014-2019) (K Units)
Table Europe Drugs for Rheumatoid Arthritis Sales Market Share by End User (2014-2019)
Figure 2018 Europe Drugs for Rheumatoid Arthritis Market Share by End User
Figure Asia Pacific Drugs for Rheumatoid Arthritis Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Drugs for Rheumatoid Arthritis Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Drugs for Rheumatoid Arthritis Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Drugs for Rheumatoid Arthritis Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Drugs for Rheumatoid Arthritis Sales Market Share by Countries
Table Asia Pacific Drugs for Rheumatoid Arthritis Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Drugs for Rheumatoid Arthritis Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Drugs for Rheumatoid Arthritis Revenue Market Share by Countries
Figure China Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure China Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Japan Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Korea Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure India Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure India Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Australia Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Drugs for Rheumatoid Arthritis Sales by Product (2014-2019) (K Units)
Table Asia Pacific Drugs for Rheumatoid Arthritis Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Drugs for Rheumatoid Arthritis Market Share by Product
Table Asia Pacific Drugs for Rheumatoid Arthritis Sales by End User (2014-2019) (K Units)
Table Asia Pacific Drugs for Rheumatoid Arthritis Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Drugs for Rheumatoid Arthritis Market Share by End User
Figure Central & South America Drugs for Rheumatoid Arthritis Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Drugs for Rheumatoid Arthritis Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Drugs for Rheumatoid Arthritis Sales by Countries (2014-2019) (K Units)
Table Central & South America Drugs for Rheumatoid Arthritis Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Drugs for Rheumatoid Arthritis Sales Market Share by Countries
Table Central & South America Drugs for Rheumatoid Arthritis Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Drugs for Rheumatoid Arthritis Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Drugs for Rheumatoid Arthritis Revenue Market Share by Countries
Figure Brazil Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Drugs for Rheumatoid Arthritis Sales by Product (2014-2019) (K Units)
Table Central & South America Drugs for Rheumatoid Arthritis Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Drugs for Rheumatoid Arthritis Market Share by Product
Table Central & South America Drugs for Rheumatoid Arthritis Sales by End User (2014-2019) (K Units)
Table Central & South America Drugs for Rheumatoid Arthritis Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Drugs for Rheumatoid Arthritis Market Share by End User
Figure Middle East and Africa Drugs for Rheumatoid Arthritis Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Drugs for Rheumatoid Arthritis Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Drugs for Rheumatoid Arthritis Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Drugs for Rheumatoid Arthritis Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Drugs for Rheumatoid Arthritis Sales Market Share by Countries
Table Middle East and Africa Drugs for Rheumatoid Arthritis Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Drugs for Rheumatoid Arthritis Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Drugs for Rheumatoid Arthritis Revenue Market Share by Countries
Figure GCC Countries Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Drugs for Rheumatoid Arthritis Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Drugs for Rheumatoid Arthritis Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Drugs for Rheumatoid Arthritis Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Drugs for Rheumatoid Arthritis Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Drugs for Rheumatoid Arthritis Market Share by Product
Table Middle East and Africa Drugs for Rheumatoid Arthritis Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Drugs for Rheumatoid Arthritis Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Drugs for Rheumatoid Arthritis Market Share by End User
Table AbbVie Inc Company Details
Table AbbVie Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Inc Recent Development

Table Hoffman-La Roche AG Company Details
Table Hoffman-La Roche AG Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hoffman-La Roche AG Recent Development

Table Amgen Inc Company Details
Table Amgen Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Inc Recent Development

Table Pfizer Inc Company Details
Table Pfizer Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc Recent Development

Table Bristol-Myers Squibb Co Company Details
Table Bristol-Myers Squibb Co Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Co Recent Development

Table Johnson & Johnson Company Details
Table Johnson & Johnson Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development

Table UCB Biosciences Inc Company Details
Table UCB Biosciences Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table UCB Biosciences Inc Recent Development

Table Mitsubishi Tanabe Pharma Corp Company Details
Table Mitsubishi Tanabe Pharma Corp Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mitsubishi Tanabe Pharma Corp Recent Development

Table Biogen Inc Company Details
Table Biogen Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Inc Recent Development

Table Merck & Co Company Details
Table Merck & Co Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co Recent Development

Table Market Segment by Product Type Company Details
Table Pharmaceuticals Company Details
Table Biopharmaceuticals Company Details
Table Global Drugs for Rheumatoid Arthritis Sales Forecast by Regions 2019-2025 (K Units)
Table Global Drugs for Rheumatoid Arthritis Sales Market Share Forecast by Regions 2019-2025
Table Global Drugs for Rheumatoid Arthritis Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Drugs for Rheumatoid Arthritis Revenue Market Share Forecast by Regions 2019-2025
Table Global Drugs for Rheumatoid Arthritis Sales Forecast by Product 2019-2025 (K Units)
Table Global Drugs for Rheumatoid Arthritis Sales Market Share Forecast by Product 2019-2025
Table Global Drugs for Rheumatoid Arthritis Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Drugs for Rheumatoid Arthritis Revenue Market Share Forecast by Product 2019-2025
Table Global Drugs for Rheumatoid Arthritis Sales Forecast by End User 2019-2025 (K Units)
Table Global Drugs for Rheumatoid Arthritis Sales Market Share Forecast by End User 2019-2025
Figure North America Drugs for Rheumatoid Arthritis Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Drugs for Rheumatoid Arthritis Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Drugs for Rheumatoid Arthritis Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Drugs for Rheumatoid Arthritis Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Drugs for Rheumatoid Arthritis Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Drugs for Rheumatoid Arthritis Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Drugs for Rheumatoid Arthritis Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Drugs for Rheumatoid Arthritis Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Drugs for Rheumatoid Arthritis Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Drugs for Rheumatoid Arthritis Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Drugs for Rheumatoid Arthritis Value Chain
Table Drugs for Rheumatoid Arthritis Customers List
Table Drugs for Rheumatoid Arthritis Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources